Send Enquiry
CURE
Tablets
Packaging and packing Type
Blister | 10x10
MRP :
₹68
PTR :
₹48.57
PTS :
₹43.71
An anti-hyperglycemic agent that is primarily used for the management of type 2 diabetes mellitus. An oral antidiabetic agent that decreases insulin ... Read More
Composition
Send Enquiry
India’s Largest Pharma Franchise
100%
Genuine Products
Secure
Payments
24 x 7
Customer Support
About the product
An anti-hyperglycemic agent that is primarily used for the management of type 2 diabetes mellitus. An oral antidiabetic agent that decreases insulin resistance in adipose tissue, liver, and muscles. (Pablos-Velasco, 2010) Improves sensitivity to insulin in muscle and adipose tissue and inhibits hepatic gluconeogenesis. (Pablos-Velasco, 2010) Effectively improves blood glucose levels, long-term glucose control, and the lipid profile in patients with type 2 diabetes mellitus. (Andreas Pfützner, 2006) An attractive and effective treatment option for managing type 2 diabetes mellitus. (Andreas Pfützner, 2006) Significantly improves HbA1c and FPG while producing beneficial effects on serum lipids in patients with type 2 diabetes. (S Aronoff, 2000) Exerts additional beneficial vascular effects in patients with type 2 diabetes mellitus. (Keiichiro Harashima, 2009) A well-tolerated agent in patients with varying degrees of renal impairment. (Klemens Budde, 2003) Improves insulin resistance in Type 2 diabetes without inducing insulin secretion from pancreatic β-cells, thereby reducing the risk of hypoglycemia. (Klemens Budde, 2003) Controls blood sugar levels by increasing the body's sensitivity to insulin, a hormone that regulates glucose metabolism. Ameliorates glycaemic control, by lowering fasting and postprandial blood glucose levels, and improves insulin sensitivity. (Michaela Diamant, 2003) Alleviates insulin resistance associated with type 2 diabetes and improves hyperglycemia, reducing HbA1c levels. (Toyota, 2001) Offers an effective approach to reducing measures of cardiovascular risk and arteriosclerosis. (John Waugh, 2006) A more beneficial treatment option for managing coronary artery disease progression in individuals with type 2 diabetes. (Steven E Nissen & Investigators, 2008)
Weight gain, Edema, Anemia, Low blood sugar, Headache, Loss of appetite
Type 2 diabetes mellitus
Temp data
Storage Condition
Product details for storage condition Product details for storage condition Product details for storage condition Product details for storage condition
Similar Products
No products found.
Send Enquiry
Request a callback to get more information about becoming a PCD Franchise Owner